AOJ Medical Receives CE(MDR) Certificate Under the New European Medical Device Regulation

Author : AOJ Medical

Update time : 2022-11-04 15:32:48

AOJ Medical, a product-focused provider of medical device supply chain services, has received CE (MDR) certificate in compliance with the new European Medical Device Regulation (MDR (EU) 2017/745) in October, 2022.

The CE(MDR) certificate includes all product lines of AOJ medical: non-invasive blood pressure monitors(NIBP), pulse oximeters and digital thermometers, which makes AOJ Medical become the first batch of medical device manufacturers in China who have obtained the CE(MDR) certificate, issued by TÜV SÜD.

CE(MDR) Certificate

As the “VISA” to enter the EU (European Union) market, CE certificate is the critical requirement for all the product which can be sold in EU. The MDR (Medical Device Regulation) has replaced the previous MDD (Medical Device Directive) since May 2020, with the aim to establish a modernized and more robust EU legislative framework to ensure better protection of public health and patient safety.

Compared with the Medical Device Directive (MDD), the MDR is stricter in product risk management, product performance safety standards, clinical evaluation, and post-market vigilance and supervision. At the same time, it is also a challenge to the medical manufacturer's quality management system, product safety, and effectiveness.

AOJ Medical pay great attention to global certifications
As a medical device manufacturer, since established, AOJ Medical has consistently invested in R&D as well as quality and regulatory compliance.

AOJ Medical will take this opportunity to pay more attention to product quality and safety, and continue to help our customers develop the EU market and the global market.

Previous : AOJ MEDICAL Attend MEDICA Trade Fair 2022

Next : FIME 2022 Completed Successfully

Revolutionizing Hypertension Management

Jun .22.2026

AOJ Medical actively turns the "home clinic" concept into reality. Specifically, we achieve this through our FDA-approved 4G blood pressure monitors.

Mastering the Economics of RPM

Jun .20.2026

Remote Patient Monitoring (RPM) serves as a powerful financial engine for modern medical practices. However, many healthcare providers fail to maximize their initial return on investment (ROI).

Why Cellular RPM Devices is the Gold Standard for US RPM Success

Jun .18.2026

Connectivity dictates the success of Remote Patient Monitoring (RPM) programs in the United States market. Choosing the wrong connection type frequently causes vital health programs to fail.

Home vs Office Readings: Decoding White Coat Hypertension and Masked Hypertension

Jun .16.2026

Have you ever wondered why your blood pressure readings change? Many patients notice differences between home and hospital measurements.